Oramed Pharmaceuticals Inc. — Director's Dealing 2009

Jan 13, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP.OB)
CIK: 0001176309
Period of Report: 2009-01-11

Reporting Person: JACOB HAROLD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-01-11	Stock Option (right to buy)	$0.43	A	300000	Acquired	2019-01-10	Common Stock (300000)	Direct

Footnotes

F1: 100,000 will vest on each of January 1, 2010, January 1, 2011 and January 1, 2012.